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SUMMARY 
Background: Orbital exenteration (OE) is a disfigur-
ing procedure which typically involves removal of the 
entire contents of the orbit including the periorbita, 
appendages, eyelids and, sometimes, a varying amount 
of surrounding skin and bone. It results in devastating 
functional, aesthetic and psychological losses.  
Design: This study reports an experience of OE in a 
Teaching Hospital in Accra Ghana. 
 Method: The records of all patients who underwent 
OE between November 2005 and October 2009 were 
reviewed retrospectively. These were cases seen at the 
orbit and oculoplastic clinic of the eye unit.  
Results: A total of 25 patients underwent OE. Nineteen 
(76%) of these were for invasive orbital squamous cell 
carcinomas and six (24%) were for other cases. Only 
one patient had OE for a benign condition (orbital 
haemangioma). Four patients had lid sparing proce-
dures. One of these was for a patient with extensive 
ocular surface squamous cell carcinoma. Five patients 
had recurrent tumours. Among those patients with 
squamous cell carcinoma, seven had previous proce-
dures, sometimes multiple before reporting to our clin-
ic.  
Conclusion: Orbital exenterations in developing coun-
tries are mostly for neglected periorbital and ocular 
surface malignancies. Educating patients to seek medi-
cal attention as soon as they notice a persistent con-
junctival growth could prevent this. 
 
Keywords: orbital exenteration, orbital tumours, 




Orbital exenteration (OE) is a disfiguring procedure 
which typically involves removal of the entire contents 
of the orbit including the periorbita, appendages, eye-
lids and, sometimes, a varying amount of surrounding 
skin and bone. OE results in devastating functional, 
aesthetic and psychological losses.  
 
It is therefore reserved for the treatment of potentially 
life-threatening malignancies arising from the orbit, 
paranasal sinuses or periocular skin.1  
 
OE has not been shown to produce a cure in most cases 
but controls local disease and may prolong life, some-
times, when used with other adjuvant therapy (chemo-
therapy and radiotherapy).2 In developing countries, 
where patients present with advanced fungating tu-
mours, the procedure may improve the quality of life 
for the rest of their life time. Occasionally it has been 
used in the management of benign tumours or orbital 
infections refractive to other modes of treatment.2,3  
Often the orbit is reconstructed to improve cosmesis 
and also to facilitate the application of prosthesis.  
  
Among several classifications of OE is that by Meyer 
and Zaoli who, in 1971, classified OE into four catego-
ries in relation to the extent of destruction involved in 
the surgery4 as follows: 
 
Type I: palpebral skin and conjunctiva are spared; 
Type II: only the palpebral skin is spared and the eye-
ball and its appendages are removed with the conjunc-
tiva; 
Type III: both eyelids are removed with orbital con-
tents; 
Type IV: the eyeball, eyelids and appendages of the 
eye are removed with the involved bone structures. 
 
Yeatts divided OE into 2 categories (a) total exentera-
tion which involves the removal of the entire orbital 
content with or without sacrifice of the eyelid skin and 
(b) subtotal involving partial removal of orbital tissues 
with sacrifice of the eye.5 Other classifications have 
been developed by Cordeiro and Santamaria.3,6 Several 
techniques for cosmetic repair have also been de-
scribed.7-10  However in some cases the orbit is left to 
granulate.3 This study reports our experience of OE in a 










The records of all patients who underwent OE between 
November 2005 and October 2009 were reviewed ret-
rospectively. These were cases seen at the orbit and 
oculoplastic clinic of the eye unit. All patients had bi-
opsy and CT scan evaluation before surgery. The orbit 
was left to granulate in all patients. Tumours from ad-
jacent structures invading the orbit, retinoblastomas 
and burkits lymphomas in children were not managed 
in this clinic. Patients with recurrence or histological 
suggestion of incomplete excision were referred for 
radiotherapy. Data was collected from histopathologi-
cal reports, and case note.  
 
Data for all exenterations performed and their diagno-
sis were obtained from theatre records. Some case 
notes were missing and some patients defaulted in fol-
low up. Data was therefore incomplete for some pa-
tients. Data on Age, sex, clinical presentation, indica-
tions for surgery, histopathological diagnosis, HIV 
status, adjuvant treatment and outcome was collected. 
As data was missing for some patients, each set of data 
was analysed separately. 
 
RESULTS 
A total of 104 patients with malignant tumours of the 
orbit and adnexa were seen during the period under 
review (data unpublished). Sixty eight of these were 
orbital tumours. Twenty five of the orbital tumours 
were orbital extensions of ocular surface or eyelid 
squamous cell carcinomas (SCC). Six cases of SCC 
were found to be too advanced and would not benefit 
from surgery. These were referred for radiotherapy.  
None of them showed signs of regression during the 
period of follow up and were subsequently lost to fol-
low up. The youngest patient for OE was 11 years and 
the old- est 88 years. The M:F=1:2.6. Age sex distribu-
tion is found in Table 1 
 
Table 1 Age and sex distribution 
Age Male Female Total (%) 
10-25 - 4 4  (16) 
26-40 1 6 7 (28) 
41-55 4 5 9 (36) 
56-70 2 1 3 (12) 
70+ - 2 2 (8) 
TOTAL 7 (28%) 18(72%) 25 
 
Out of 25 patients who underwent OE 19 (76%) were 
for invasive orbital squamous cell carcinomas and six 
(24%) were for other cases including one patient with a 
benign condition (orbital haemangioma) (Tables 2 and 




Table 2 Characteristics of Orbital Exenteration in patients other than SCC 
Age Sex R/L Presentation Diagnosis HIV Status Operation Result 
22 F L 0rbital mass 
Disorg. Ant seg 
Uveal Malignant mela-
noma 
Positive Lid Sparing Recurrent 
31 F L Orbital tumour Adenoid cystic ca Not Known Total Ref/Lost 
20 F R Orbital tumour Chondrosarcoma Negative Lid Sparing Recurrent 
35 F L Pagetoid  upper 
lids, fornix, ant 
orbit 
Sebaceous carcinoma Positive Total Healed 
11 F L Massive orbital 




Negative Lid Sparing Healed 
14 F R Sino orbital tumour Alveolar Rhabdomyo-
sarcoma 
Negative Total Ref/Lost 
 
One of these was for a patient with extensive ocular 
surface squamous cell carcinoma (patient 14, Table 3). 
The rest had total OE. It is difficult to report on the 
outcome because of the large numbers lost to follow up 
and incomplete data. With the available data (Tables 2 
and 3), 10 (40%) of the 25 patients were lost to follow 
up, some of these were referred for radiotherapy and/or 
chemotherapy. Five patients had recurrent tumours 
some with extension to adjacent structures. Ten pa-
tients healed completely some with adjuvant radiother-
apy, as at last follow up (for periods ranging from 4 to 
8 months).  
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The commonest complication was sino-orbital fistulas, 
which were recorded in 5 (20%) patients. In the pa-
tients with squamous cell carcinoma, at least seven 
patients had previous procedures, sometimes multiple 
before reporting to our clinic (Table 3). 
 




Age  Sex 
HIV sta-
tus Tumour Extent 
Previous Ex-
cision Outcome 
1.  29 F Pos Lost data Lost data Fistular/healed 
2.  46 M Positive Lost data Yes Lost 
3.  42 F Positive Medial bulbar/ant orbit/ocular 2 yes Healed 
4.  42 M Negative Entire ocular surface/no ocular Lost data Fistular/healed 










7.  44 F Positive Entire ocular surface/ant or-
bit/ocular 
Yesx4 Lost 
8.  36 F Positive Entire ocular surface/inf forni-
ceal/ 
Nil Healed 
9.  56 M ? Fungating tumour /ant or-
bital/ocular/ 
No Lost 
10.  28 M Positive Entire Ocular surface Lost data Healed 
11.  50  
M 





No loc Al 
rec/fistular/ 
12.  45 M Positive Large Lower fornix obsc, eye No Rec/max/died 
13.  69 F Negative Fungating orbital/ocular Lost data Intracranial ext. 
14.  88 F Lost data Large medial bulbar/ant. Inf. Or-
bit. No ocular 
Lost data Lost data 
15.  27 F Positive Palpebral conjunctivitis Yes+eviscerat
ion 
Healed 
16.  61 M Negative Entire bulbar/anterior or-
bit/ocular 
Nil Healed 
17.  46 F Negative Large bulbar/ocular/anterior or-
bit 
Yes 2x Rec/fistular/max 
ext. 
18.  80 F Negative Fungating tumour arising from 
conjunctiva 
Lost data Lost data 
19.  50 F Lost data Lost data Lost data Lost data 
 
Rec=tumour recurrence; fistula=sino-orbital fistula; max ext=maxillary extension 
 
DISCUSSION 
Orbital exenterations (OE) are commonly performed 
with various techniques (myocutaneous flaps implanta-
tion, eyelid-sparing exenteration with myocutaneous 
flap, and dermis fat implants) to improve cosmesis.7-10 
These techniques offer rapid healing and provide for 
the application of prosthesis. However they are not 
suitable in cases where tumour recurrence is likely. 
Sometimes the orbit is left to granulate.3,11  
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The latter technique was chosen in all our patients be-
cause of the extent of the tumors seen and the possibil-
ity of high recurrence rates.   Moreover this technique 
is simple and produces cosmetically better results for 
patients not wearing prosthesis. Spontaneous granula-
tion technique is employed for cases where tumour 
clearance is not guaranteed. Others would employ in-
stead delayed orbital reconstruction12 using dermis-fat 
graft and temporalis transfer. But even these techniques 
are usually reserved for more benign and less aggres-
sive tumours.10,12-14 
  
A majority of patients (76%) in this study were ne-
glected invasive squamous cell carcinomas (SCC) aris-
ing from the conjunctiva invading the orbit. Although 
conjunctival SCC is known to be relatively non-
aggressive tumour, especially in Caucasians, a few 
studies from tropical and subtropical regions suggest 
that in these areas, this type of cancer behaves in an 
aggressive fashion and tends to affect younger individ-
uals.14,15 This study supports these reports in that there 
was extensive orbital invasion of conjunctival SCC in 
our patients.  
  
A good proportion of the patients had had previous 
surgeries for earlier stages of conjunctival lesions rang-
ing from single or multiple excisions to evisceration 
and enucleations. Some of these tumours subsequently 
invaded the eyeball and the orbit. This situation high-
lights the lack of adequate management of early stages 
of SCC and lack of follow up on these patients. Ma-
heshwari reported a similar situation in an Indian 
study.3   
 
It is not possible to comment on survival rates of our 
patients because of poor follow up. Some of these pa-
tients might have died at home since some come from 
places very far from our centre. In a study among elder 
patients who had OE in Italy, Groce et al reported a 
high rate of tumour related - mortality (5 out of 7).2 
These were in patients with multiple recurrent cases; 
three of these were from SCC. This and other studies 
suggest that OE tends to be palliative for advanced 
tumours. With the high rate of default in follow up 
attendance in developing countries, these situations are 
not uncommon.Some end up with practitioners of al-
ternative medicine and die in their hands. However 
other studies report improved mortality with more radi-
cal surgery combined with adjuvant therapy.12  
 
The only complication we had was sino-orbital fistulae. 
This is the commonest complication of OE reported in 
literature.16 Sino-orbital fistulae are commoner follow-
ing post-operative radiotherapy but may occur when 
there is damage to the thin medial wall or floor of the 
orbit.  
It may be repaired with muscle flaps or skin graft. In 
our cases, they were left to heal over several weeks. 
Others have reported leaking cerebrospinal fluid and 
socket shrinkage.3 
 
Other studies on OE reported fewer numbers, the ma-
jority were for lesions affecting the orbit. A study from 
India reported 15 OE in a ten year period, 54% origi-
nating from the eyelids, 33% from the orbit and 13% 
from the conjunctiva 3. Most of their cases were also 
for neglected tumours that could have been spared OE 
if patients had been seen earlier. In a study in Turkey 
spanning a period of 30 years, 429 cases of OE were 
reported11 40% of which were for tumours of eyelid 
origin and only 13% for primary conjunctival tumours. 
However SCC was the most frequent indication for 
OE, accounting for over 30% of all cases.  
 
Basal cell carcinomas have been reported as the major 
indications for OE in these and other studies.(2,9,10)  
Other studies from tropical regions show a preponder-
ance of SCC as indication for OE3. In this study most 
of our patients had neglected ocular surface SCC. It has 
been suggested that people in tropical regions are pre-
disposed to squamous cell carcinoma of the conjuncti-
va due to solar radiation and high prevalence of HIV. 
Also in areas where eye care services are inadequate 
patients tend to present late with tumours of the eye 
and adnexa. This may account for the large numbers of 
people requiring OE, and requiring OE for secondary 
tumours as opposed to primary orbital tumours in de-
veloped countries.  
 
There is a preponderance of females in this study. It 
has been suggested that women in deprived areas are 
disadvantaged when it comes to eye care. They depend 
on their husbands for permission and financial support. 
These are usually denied till late in the course of the 
disease.  
 
Limitations of this study include incomplete data for 
some of the patients due to poor follow up records. The 




This study discusses an experience with orbital exen-
teration in a developing country with limited resources 
and late presentation of most patients. It supports other 
studies suggesting that orbital exenterations in develop-
ing countries are most of the time performed for ne-
glected periorbital and ocular surface malignancies. 
Educating patients to seek early medical attention for 
persistent conjunctival growths could prevent this. 
Conjunctival tumours should be adequately managed at 
first presentation to prevent recurrences, which are 
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